<!-- Page: 1 -->

# AI-Powered AAV Capsid Design

Engineering Next-Generation Gene Delivery via In Silico Evolution

![image](https://static-us-img.skywork.ai/prod/nexus/1766446253/cropped_image_2_1766446253296724632.jpg)

## The Challenge: The Delivery Bottleneck

## â€¢ Problem:

Natural AAVs lack â€œGPSâ€ â€“ often end up in the liver instead of the target organ.

![image](https://static-us-img.skywork.ai/prod/nexus/1766446253/cropped_image_6_1766446253300824970.jpg)

![image](https://static-us-img.skywork.ai/prod/nexus/1766446253/cropped_image_7_1766446253301404711.jpg)

> Natural AAV

![image](https://static-us-img.skywork.ai/prod/nexus/1766446253/cropped_image_9_1766446253302373865.jpg)

> Liver

![image](https://static-us-img.skywork.ai/prod/nexus/1766446253/cropped_image_11_1766446253303489790.jpg)

> Target Brain

- Scale: The possible variations of a 7-mer peptide insertion are vast \((1.28 \times 10^{9}\) sequences), making physical testing impossible.

![chart](https://static-us-img.skywork.ai/prod/nexus/1766446253/cropped_image_14_1766446253310131387.jpg)

## â€¢ Risk:

![image](https://static-us-img.skywork.ai/prod/nexus/1766446253/cropped_image_16_1766446253311873692.jpg)

High immunogenicity and low packaging efficiency (manufacturability)

> Site 538

![image](https://static-us-img.skywork.ai/prod/nexus/1766446253/cropped_image_19_1766446253313475790.jpg)

## Results: From Billions to Units
11 potential targets identified by AI

1.28

Billion Variants
screened entirely
in silico

![image](https://static-us-img.skywork.ai/prod/nexus/1766446253/cropped_image_23_1766446253318941604.jpg)

40% Reduction
Predicted
immunogenicity risk

3

Lead Candidates
Optimized for CNS
(Central Nervous
System) tropism

500+

Variants
Proprietary
sequence-to-function
database established

## 2 Methodology: The AI Filtration Pipeline

![image](https://static-us-img.skywork.ai/prod/nexus/1766446253/cropped_image_30_1766446253332515763.jpg)

![image](https://static-us-img.skywork.ai/prod/nexus/1766446253/cropped_image_31_1766446253335887218.jpg)

![image](https://static-us-img.skywork.ai/prod/nexus/1766446253/cropped_image_32_1766446253338642332.jpg)

![image](https://static-us-img.skywork.ai/prod/nexus/1766446253/cropped_image_33_1766446253341321873.jpg)

![image](https://static-us-img.skywork.ai/prod/nexus/1766446253/cropped_image_34_1766446253342181269.jpg)

> Site 266

## 4 Impact: Rational Design vs. Trial & Error

> Trial & Error

![image](https://static-us-img.skywork.ai/prod/nexus/1766446253/cropped_image_38_1766446253347762241.jpg)

![image](https://static-us-img.skywork.ai/prod/nexus/1766446253/cropped_image_39_1766446253348969835.jpg)

> Precision

> Months of lab work

> Days of compute

![image](https://static-us-img.skywork.ai/prod/nexus/1766446253/cropped_image_43_1766446253356459681.jpg)

![image](https://static-us-img.skywork.ai/prod/nexus/1766446253/cropped_image_44_1766446253358051105.jpg)

> Targets CNS, Heart, Kidney, and Muscle with surgical accuracy

A modular platform adaptable for any genetic disease

â—‡

<!-- ALEXION -->

ðŸ”§

BioClarityAI

<!-- BioClarityAI -->